EP3102604

COMBINATION OF A PD-1 ANTAGONIST AND A 4-1BB AGONIST FOR TREATING CANCER

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    3.2.2015
  • EP published:
    15.1.2020
  • EP application number:
    15703438.0
  • Max expiry date:
    2.2.2035
  • Title:
    COMBINATION OF A PD-1 ANTAGONIST AND A 4-1BB AGONIST FOR TREATING CANCER

Timeline

Today
3.2.2015EP application
15.1.2020EP Publication

Owner

  • Name:
    Pfizer Inc.
  • Address:
    235 East 42nd Street, New York, NY 10017, US
  • Name:
    Merck Sharp & Dohme Corp.
  • Address:
    126 East Lincoln Avenue, Rahway, NJ 07065, US

Inventor

  • Name:
    DAVIS, Craig, Bennett
  • Address:
    Groton, CT 06340, US
  • Name:
    KOEHLER, Maria, Theresa
  • Address:
    Narberth, PA 19072, US
  • Name:
    YAN, Li
  • Address:
    North Wales, PA 19454, US

Priority

  • Number:
    201461935748 P
  • Date:
    4.2.2014
  • Country:
    US

Classification

  • Categories:
    C07K 16/28, A61P 35/00, A61K 39/35

Upload documents